<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81316</article-id><article-id pub-id-type="doi">10.7554/eLife.81316</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Physics of Living Systems</subject></subj-group></article-categories><title-group><article-title>Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-246888"><name><surname>Recktenwald</surname><given-names>Steffen M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1235-1521</contrib-id><email>steffen.recktenwald@uni-saarland.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-285058"><name><surname>Simionato</surname><given-names>Greta</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5452-2275</contrib-id><email>greta.simionato@uni-saarland.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285059"><name><surname>Lopes</surname><given-names>Marcelle GM</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9668-5504</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-285060"><name><surname>Gamboni</surname><given-names>Fabia</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0855-9138</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-218861"><name><surname>Dzieciatkowska</surname><given-names>Monika</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-285061"><name><surname>Meybohm</surname><given-names>Patrick</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2666-8696</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-285062"><name><surname>Zacharowski</surname><given-names>Kai</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0212-9110</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-285063"><name><surname>von Knethen</surname><given-names>Andreas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5831-0365</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-285064"><name><surname>Wagner</surname><given-names>Christian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7788-4594</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-93185"><name><surname>Kaestner</surname><given-names>Lars</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6796-9535</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-218864"><name><surname>D'Alessandro</surname><given-names>Angelo</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-285065"><name><surname>Quint</surname><given-names>Stephan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4412-7559</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01jdpyv68</institution-id><institution>Dynamics of Fluids, Department of Experimental Physics, Saarland University</institution></institution-wrap><addr-line><named-content content-type="city">Saarbrücken</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01jdpyv68</institution-id><institution>Institute for Clinical and Experimental Surgery, Campus University Hospital, Saarland University</institution></institution-wrap><addr-line><named-content content-type="city">Homburg</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>Cysmic GmbH</institution><addr-line><named-content content-type="city">Saarbrücken</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02hh7en24</institution-id><institution>Department of Biochemistry and Molecular Genetics, University of Colorado Denver</institution></institution-wrap><addr-line><named-content content-type="city">Aurora</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03pvr2g57</institution-id><institution>Department of Anesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Wuerzburg</institution></institution-wrap><addr-line><named-content content-type="city">Wuerzburg</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03f6n9m15</institution-id><institution>Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt</institution></institution-wrap><addr-line><named-content content-type="city">Frankfurt</named-content></addr-line><country>Germany</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01s1h3j07</institution-id><institution>Fraunhofer Institute for Translational Medicine and Pharmacology ITMP</institution></institution-wrap><addr-line><named-content content-type="city">Frankfurt</named-content></addr-line><country>Germany</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/036x5ad56</institution-id><institution>Department of Physics and Materials Science, University of Luxembourg</institution></institution-wrap><addr-line><named-content content-type="city">Luxembourg City</named-content></addr-line><country>Luxembourg</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01jdpyv68</institution-id><institution>Theoretical Medicine and Biosciences, Campus University Hospital, Saarland University</institution></institution-wrap><addr-line><named-content content-type="city">Homburg</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Baiocchi</surname><given-names>Robert</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rs6vg23</institution-id><institution>The Ohio State University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>20</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e81316</elocation-id><history><date date-type="received" iso-8601-date="2022-06-22"><day>22</day><month>06</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-11-27"><day>27</day><month>11</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-03-31"><day>31</day><month>03</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.03.31.22273226"/></event></pub-history><permissions><copyright-statement>© 2022, Recktenwald, Simionato et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Recktenwald, Simionato et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81316-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-81316-figures-v1.pdf"/><abstract><p>Coronavirus disease 2019 (COVID-19) is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and can affect multiple organs, among which is the circulatory system. Inflammation and mortality risk markers were previously detected in COVID-19 plasma and red blood cells (RBCs) metabolic and proteomic profiles. Additionally, biophysical properties, such as deformability, were found to be changed during the infection. Based on such data, we aim to better characterize RBC functions in COVID-19. We evaluate the flow properties of RBCs in severe COVID-19 patients admitted to the intensive care unit by using microfluidic techniques and automated methods, including artificial neural networks, for an unbiased RBC analysis. We find strong flow and RBC shape impairment in COVID-19 samples and demonstrate that such changes are reversible upon suspension of COVID-19 RBCs in healthy plasma. Vice versa, healthy RBCs resemble COVID-19 RBCs when suspended in COVID-19 plasma. Proteomics and metabolomics analyses allow us to detect the effect of plasma exchanges on both plasma and RBCs and demonstrate a new role of RBCs in maintaining plasma equilibria at the expense of their flow properties. Our findings provide a framework for further investigations of clinical relevance for therapies against COVID-19 and possibly other infectious diseases.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>red blood cells</kwd><kwd>COVID-19</kwd><kwd>microfluidics</kwd><kwd>omics</kwd><kwd>blood</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020 Framework Programme</institution></institution-wrap></funding-source><award-id>860436</award-id><principal-award-recipient><name><surname>Lopes</surname><given-names>Marcelle GM</given-names></name><name><surname>Wagner</surname><given-names>Christian</given-names></name><name><surname>Kaestner</surname><given-names>Lars</given-names></name><name><surname>Quint</surname><given-names>Stephan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>WA 1336/13-1</award-id><principal-award-recipient><name><surname>Recktenwald</surname><given-names>Steffen M</given-names></name><name><surname>Simionato</surname><given-names>Greta</given-names></name><name><surname>Wagner</surname><given-names>Christian</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100005690</institution-id><institution>Universität des Saarlandes</institution></institution-wrap></funding-source><award-id>Open Access Publication Funding</award-id><principal-award-recipient><name><surname>Recktenwald</surname><given-names>Steffen M</given-names></name><name><surname>Simionato</surname><given-names>Greta</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>For severe COVID-19 patients' red blood cells, healthy donor plasma reduces pathological red blood cell shape alterations and improves microcapillary flow in vitro through an interaction between red blood cells and plasma.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) can lead to the development of the Coronavirus disease 2019 (COVID-19) (<xref ref-type="bibr" rid="bib56">Wu et al., 2020</xref>). The pathophysiology of COVID-19 is characterized by respiratory manifestations but also involves increased inflammatory responses (<xref ref-type="bibr" rid="bib32">Mehta et al., 2020</xref>), alterations in the number and phenotype of blood cells (<xref ref-type="bibr" rid="bib30">Mann et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Kubánková et al., 2021</xref>), microthrombotic complications, and vascular occlusions that can be fatal (<xref ref-type="bibr" rid="bib51">Tang et al., 2020</xref>; <xref ref-type="bibr" rid="bib54">Varatharajah and Rajah, 2020</xref>; <xref ref-type="bibr" rid="bib17">Della Rocca et al., 2021</xref>). In these changes, red blood cells (RBCs) were found to exhibit structural protein damage, membrane lipid remodeling (<xref ref-type="bibr" rid="bib52">Thomas et al., 2020a</xref>), dysregulation in serum levels of coagulation factors (<xref ref-type="bibr" rid="bib13">D’Alessandro et al., 2020</xref>), as well as altered physical and rheological properties, such as shape, size, and deformability (<xref ref-type="bibr" rid="bib25">Kubánková et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Renoux et al., 2021</xref>). Changes in RBC mechanical properties, such as its bending rigidity and cytoplasm viscosity, can dramatically alter their morphology, reduce microvascular perfusion, damage the endothelial cells lining the blood vessel walls, and impact flow behavior and hemorheology of blood in the circulatory system, eventually affecting gas transport efficiency (<xref ref-type="bibr" rid="bib28">Lipowsky, 2005</xref>; <xref ref-type="bibr" rid="bib31">Matthews et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Lanotte et al., 2016</xref>; <xref ref-type="bibr" rid="bib18">Di Carlo, 2012</xref>; <xref ref-type="bibr" rid="bib38">Piety et al., 2021</xref>; <xref ref-type="bibr" rid="bib10">Caruso et al., 2022</xref>). Such effects may play a role in COVID-19 severity. However, the origin of pathological changes of COVID-19 RBCs and their impact on blood flow remains poorly understood. RBC flow properties are particularly relevant in the microvasculature, especially in capillaries, where gas exchanges and microthrombotic events occur. Recently, <xref ref-type="bibr" rid="bib25">Kubánková et al., 2021</xref> studied the microfluidic flow of RBCs from COVID-19 patients suspended a in phosphate-buffered saline (PBS) solution in a channel with a cross-section of 20 × 20 µm<sup>2</sup>, resulting in cell velocities up to 30 cm s<sup>-1</sup>. At such high velocities, RBC deformability turned out to be heterogeneous, with most of the RBCs being strongly elongated in the flow direction but some exhibiting circular, less deformable shapes compared with healthy controls. In human capillaries, which have diameters similar to RBC size (about 10 µm), confined flows confer to RBCs characteristic shapes that depend on the cell velocity and the surrounding medium (<xref ref-type="bibr" rid="bib20">Guckenberger et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Recktenwald et al., 2022a</xref>; <xref ref-type="bibr" rid="bib43">Recktenwald et al., 2022b</xref>). We previously used a microfluidic setup with channel dimensions similar to the RBC size and analyzed RBC shapes at high detail by means of artificial neural networks (<xref ref-type="bibr" rid="bib24">Kihm et al., 2018</xref>) in a velocity range that resembles microvascular in vivo flow. Flow properties of RBCs depend on biophysical cell features that are influenced by biochemical characteristics. In order to elucidate the effects of COVID-19 on RBCs, we study their shapes and flow properties in autologous and allogeneic plasma in similar confined microfluidic channels in comparison to healthy controls. We observe RBC flow impairment in COVID-19 plasma and a full recovery upon suspension in healthy plasma. To better understand these effects, we additionally characterize both RBCs and plasma content by proteomics and metabolomics analyses, highlighting a mutual influence between RBCs and plasma and discovering a new role of RBCs in influencing plasma homeostasis in COVID-19.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>COVID-19 patients exhibit pathological changes of RBC shapes in capillary flow</title><p>We investigate the microfluidic flow behavior of RBCs in autologous as well as in allogeneic plasma. Therefore, patient RBCs are suspended in blood group-matching control plasma and control RBCs in patient plasma. Hence, we obtain four sample groups; (i) control RBCs in control plasma (CinC), (ii) patient RBCs in patient plasma (PinP), (iii) control RBCs in patient plasma (CinP), and (iv) patient RBCs in control plasma (PinC) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). RBCs of the four sample groups are imaged in stasis for the assessment of shapes and cluster formation at rest. While healthy controls (CinC) form biconcave RBCs that organize into rouleaux, sphero-echinocytes for COVID-19 patients in autologous plasma (PinP) are found in stasis and highlight impaired RBC clustering (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). However, upon plasma exchange (PinC), COVID-19 RBC shapes in stasis revert to biconcave disks and are able to aggregate into rouleaux. The opposite trend is observed for control cells suspended in patient plasma (CinP). The ratio of RBCs in clusters over the total number of RBCs quantifies the differences between CinC and PinP and shows the recovery of patient RBCs for PinC (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>, left panel). The number of RBCs per cluster in CinC is about twice the number of PinP. Notably, patient cell shape and rouleaux formation recovery in control plasma (PinC) results in no significant differences with control RBCs (CinC) (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>, right panel).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Representative red blood cell (RBC) shapes in healthy and COVID-19 patients and related phase diagrams.</title><p>(<bold>A</bold>) Overview of the four sample groups, referred to as ‘X RBCs in X plasma’, e.g. CinC for Control RBCs in Control plasma, and so on for PinP, PinC, and CinP. (<bold>B</bold>) Representation images of RBC shapes in stasis for the four sample groups. Scale bars in (<bold>B</bold>) correspond to a length of 10  µm. Representative images of (<bold>C</bold>) healthy and (<bold>D</bold>) pathological RBC shapes found in COVID-19 patients. Scale bars in (<bold>C</bold>) and (<bold>D</bold>) correspondto a length of 2.5 μm. (<bold>E</bold>) Representative shape phase diagrams of two donors (a control and a patient) for the four sample groups. The upper panels show the phase diagrams of the donors in autologous plasma, while the lower panels correspond to the same donors in allogeneic exchanged plasma.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Patient information.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-81316-fig1-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Single-cell flow characteristics.</title><p>(<bold>A</bold>) Histograms and probability density distributions (pdfs) of the absolute value of the RBC y-position, normalized by the channel width W, at a representative low and high mean RBC velocity of 0.61 mm s<sup>−1</sup> and 5.7 mm s<sup>−1</sup>, respectively. Scale bars represent a length of 5 μm. (<bold>B</bold>) Pdfs of the normalized y-position at 5.7 mm s<sup>−1</sup> for a healthy control and two patients (P1 and P6), indicating a small and large y-deviation (gray area) between the control and the corresponding patient.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Brightfield microscopy and quantification of RBC shapes and clusters in stasis.</title><p>(<bold>A</bold>) Representative RBC images from one healthy control in autologous plasma (CinC), one COVID-19 patient (PinP), and respective plasma exchanges, with control RBCs in patient plasma (CinP) and patient RBCs in control plasma (PinC). Scale bars represent 10 μm. (<bold>B</bold>) Quantification and statistical analysis by ANOVA from seven COVID-19 patients and three healhty controls. Left panel: ratio of RBC clusters over the total number of RBCs, right panel: number of RBCs per cluster.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig1-figsupp2-v1.tif"/></fig></fig-group><p>The RBC suspensions are pumped through microfluidic channels mimicking capillary flow conditions and the RBC velocity, lateral cell position in the y-direction, and projection area of each cell are analyzed (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). In confined flows with dimensions on the same order of magnitude as the diameter of RBCs, healthy RBCs predominantly deform into centered croissants and off-centered slipper shapes (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), depending on the cell velocity. RBCs of COVID-19 patients additionally exhibit complementary pathological croissant and slipper shapes that resemble their corresponding healthy classes but display pronounced spicules on the membrane (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). Further, COVID-19 patients show sphero-echinocytes in flow, known as irreversible transformations of RBCs that can occur upon ATP depletion, high pH, or exposure to anionic detergents (<xref ref-type="bibr" rid="bib27">Lim, 2009</xref>; <xref ref-type="bibr" rid="bib2">Bernhardt and Ellory, 2013</xref>; <xref ref-type="fig" rid="fig1">Figure 1D</xref>). The so-called RBC shape phase diagram (<xref ref-type="bibr" rid="bib24">Kihm et al., 2018</xref>; <xref ref-type="bibr" rid="bib20">Guckenberger et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Recktenwald et al., 2022a</xref>; <xref ref-type="bibr" rid="bib43">Recktenwald et al., 2022b</xref>) describes the frequency of occurrence for RBC morphologies as a function of cell velocity. While croissant- and slipper-like shapes emerge for control samples in autologous plasma (CinC), corresponding pathological shapes and sphero-echinocytes dominate for patient RBCs in autologous plasma (PinP) (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, top graphs). This initial assessment highlights the dramatic shape difference between control and COVID-19 patient RBCs. However, upon plasma exchange with healthy control plasma, patient RBCs (PinC) show a shape reversal, exhibiting a phase diagram similar to healthy controls. In contrast, control RBCs in allogeneic exchanged COVID-19 plasma (CinP) result in a drastic RBC shape deterioration (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, bottom graphs).</p><p>In microcapillary flow, the fraction of pathological cells, defined as the number of pathologically shaped cells (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) divided by the total number of pathological and healthy cells (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), quantifies the extent of pathological RBC shape changes. While this fraction is considerably small for healthy controls (CinC), COVID-19 patients (PinP) show pathological fractions of up to one in autologous plasma (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Upon plasma exchange (PinC), all patients exhibit a decrease in the pathological fraction, hence a reduction in the number of pathological RBC shapes. In contrast, healthy RBCs suspended in COVID-19 plasma (CinP) show an increase in pathological shapes compared to their control condition (CinC). Similarly, suspension in allogeneic plasma results in a reduction of sphero-echinocytes for all patients, while an increase is observed for the controls in COVID-19 plasma (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The pronounced number of sphero-echinocytes in RBCs suspended in COVID-19 plasma leads to a decrease of the 2D projection area in the x-y-plane compared to healthy shapes (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The large number of sphero-echinocytes and the impaired deformability of pathological RBCs in COVID-19 plasma (PinP and CinP) hinders the formation of stable slipper-shaped RBCs at high velocities. This causes pronounced deviations from the single-cell flow behavior of healthy cells, as expressed by the deviation in the equilibrium position in y-direction (<xref ref-type="fig" rid="fig2">Figure 2D</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Parameters used for microfluidic flow analysis for the four sample groups.</title><p>(<bold>A</bold>) Fraction of pathological RBC shapes, (<bold>B</bold>) percentage of sphero-echinocytes, (<bold>C</bold>) RBC 2D projection area in a velocity range of 1-3 mm s<sup>-1</sup>, and (<bold>D</bold>) deviation of the RBC distribution in y-direction based on the average of controls (CinC) in a velocity range of 5-10 mm s<sup>-1</sup>. Left panels (<bold>A–D</bold>) show data as boxplots with superimposed individual data points. Filled symbols correspond to samples that are included in the metabolomics and proteomics analyses (<xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig4">Figure 4</xref>). The bottom and top of each box are the 25th and 75th percentiles of the sample, respectively. The line in the middle of each box is the sample median. Whiskers go from the end of the interquartile range to the furthest observation. Data beyond the whisker length are marked as outliers with ’+’ signs. * refers to a significance level of p&lt;0.05, ** to p&lt;0.01, and *** to p&lt;0.001. Right panels (<bold>A–D</bold>) show the effect of plasma exchange for individual donors. Gray areas correspond to the mean and standard deviations for controls (CinC) of the corresponding data.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig2-v1.tif"/></fig></sec><sec id="s2-2"><title>Multiomics analyses reveal a tight interaction between plasma and RBCs</title><p>To delve into the molecular underpinnings of RBC shape changes in COVID-19 and the reversal of such phenomena upon incubation with healthy control plasma, we perform multiomics analyses, including proteomics and metabolomics, of the four sample groups (CinC, PinP, PinC, and CinP). RBCs and plasma from all four conditions are investigated separately and the top 50 metabolites and proteins, which were previously found to be altered in COVID-19 samples and that exhibited the most pronounced changes, are examined.</p><sec id="s2-2-1"><title>RBCs affect plasma content</title><p>The comparison between control (CinC) and patient (PinP) plasma shows two clusters of differentially abundant proteins and metabolites (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Control plasma content results in higher levels of albumin (ALB), transferrin (TF), and gelsolin (GSN). Decreased levels of such proteins are associated with hypercoagulability, higher inflammatory state, and severity in COVID-19, respectively (<xref ref-type="bibr" rid="bib55">Violi et al., 2021</xref>; <xref ref-type="bibr" rid="bib11">Claise et al., 2022</xref>; <xref ref-type="bibr" rid="bib33">Messner et al., 2020</xref>). On the contrary, patient plasma is associated with an increase in inflammation and coagulation markers, such as complement cascade proteins (such as C2, C3, C5, C7, C9), SERPINA1, SERPINA3, and SERPINA G1 and C-reactive protein (CRP).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Metabolomics and proteomics analyses of plasma from the four sample groups.</title><p>(<bold>A</bold>) Hierarchical clustering analysis of the top 50 metabolites and proteins by two-way ANOVA test that exhibited the most pronounced changes. (<bold>B</bold>) Principal component analysis (PCA) performed on the metabolomics and proteomics plasma data presented in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref> shows distinct groups. (<bold>C</bold>) Schematic representation of tryptophan pathway to kynurenine, anthranilate, and indole acetaldehyde formation. (<bold>D</bold>) Boxplots of all samples for each group showing statistical differences in selected molecules generated in the tryptophan-kynurenine pathway. Y-axis indicates peak areas for each selected analyte, as determined by UHPLC-MS. Statistically-significant differences exist between controls (CinC) and patients (PinP) in the levels of tryptophan and anthranilate. Plasma exchanges cause strong significant differences in anthranilate levels and the ratio tryptophan-kynurenine (Trp/Kyn) in all groups, a marker of COVID-19 disease severity and mortality in previous studies (<xref ref-type="bibr" rid="bib15">D’Alessandro et al., 2021b</xref>).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>All analyzed metabolites and proteins.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-81316-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig3-v1.tif"/></fig><p>After placing RBCs of patients in control plasma (PinC) and vice versa control RBCs in patient plasma (CinP), plasma contents immediately change, influenced by RBCs. Specifically, patient plasma becomes comparable to control plasma content upon suspension with control RBCs (CinP), while the opposite effect occurs in control plasma suspended with patient RBCs (PinC) (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). This shows a strong influence of RBCs on plasma content and highlights the establishment of an equilibrium between RBCs and plasma. Notably, the fraction of pathological RBC shapes and sphero-echinocyte percentage are comparable in RBCs suspended in patient plasma, although plasma content is different. This means that RBC influence on plasma content occurs at the expense of RBC morphology, which in turn, affects RBC flow properties. Additionally, these results show that the impairment of RBC shape is not directly caused by a specific plasma component but may derive from a complex interaction between plasma and RBCs. In agreement with the data in the heat map, principal component analysis (PCA) highlights four distinct groups, showing that plasma contents of the groups CinP and CinC result in neighboring clusters, while PinC and PinP clusters strongly overlap (<xref ref-type="fig" rid="fig3">Figure 3B</xref>).</p><p>Within the identified significantly different molecules in plasma (<xref ref-type="fig" rid="fig3">Figure 3A</xref> heatmap and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>) tryptophan metabolites deserve consideration. As previously described (<xref ref-type="bibr" rid="bib53">Thomas et al., 2020b</xref>), tryptophan metabolism is altered in COVID-19 plasma, resulting in decreased anthranilate and indole acetaldehyde and increased kynurenine in patients, which is associated with a higher mortality risk (<xref ref-type="bibr" rid="bib53">Thomas et al., 2020b</xref>; <xref ref-type="bibr" rid="bib29">Mangge et al., 2021</xref>; <xref ref-type="fig" rid="fig3">Figure 3C</xref>). Compared to control conditions (CinC), plasma kynurenine significantly increases upon exposure of patient RBCs in control plasma (PinC). Tryptophan levels are significantly lower in patient plasma (PinP) compared to controls (CinC), while they significantly increase for control RBCs in patient plasma (CinP). Plasma anthranilate levels and tryptophan/kynurenine (Trp/Kyn) ratio significantly differ in the groups with control RBCs (CinC and CinP) compared to patients groups (PinC and PinP). These data suggest a role of RBCs in buffering kynurenine content and related metabolites, thus potentially protecting from an increased risk for mortality in COVID-19 patients (<xref ref-type="fig" rid="fig3">Figure 3D</xref>).</p></sec><sec id="s2-2-2"><title>Plasma components affect RBC content</title><p>Omics analyses on RBCs from each group reveal a cluster of proteins and metabolites that is comparable between CinC and PinP. Most of them involve plasma proteins, such as albumin (ALB), fibrinogen (FGA and FGB), gelsolin (GSN), transferrin (TF), serpins (SERPINA1, SEPRINC1), and immunoglobulin variables (IGHV439, IGHG2, IGKC) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>), which result significantly different in the respective control and patient plasma samples.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Metabolomics and proteomics analyses on RBCs of the four sample groups and correlation analyses with shape parameters.</title><p>(<bold>A</bold>) Hierarchical clustering analysis of the top 50 metabolites and proteins in RBCs by two-way ANOVA test that exhibited the most pronounced changes. (<bold>B</bold>) PCA analysis performed on the metabolomics and proteomics from RBC content presented in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref> showing clusters of each sample group, where CinC is neighboured by the overlapping clusters CinP and PinC, and PinP as the furthest cluster. Plasma and RBC Spearman correlation analysis of RBC shape parameters with omics data. Volcano plot representations highlight the most significant proteins and metabolites in plasma (<bold>C</bold>) and in RBCs (<bold>D</bold>) positively (red) or negatively (blue) correlated to the fraction of pathological RBC shapes (left panels in <bold>C</bold> and <bold>D</bold>) or sphero-echinocyte percentage (right panels in <bold>C</bold> and <bold>D</bold>). p values are plotted on the y-axis versus magnitude of change (fold change) on the x-axis; significance threshold is set at p&lt;0.05.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>STRING analysis of proteins in RBCs of COVID-19 patients.</title><p>STRING analysis of proteins with significantly higher levels in RBCs of COVID-19 patients in autologous plasma. Evidenced in red are proteins associated with cellular responses to stress, involving ubiquitin-protein ligase complexes (CUL2), proteasome (PSMD11) and redox activity (TXN).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>STRING analysis of positively correlated proteins with spheroechinocyte percentage, highlighting the main processes involving pathological RBCs in COVID-19.</title><p>Red: proteins involved in gas transport; green: proteasome-related proteins; purple: glutathione metabolism-related proteins.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81316-fig4-figsupp2-v1.tif"/></fig></fig-group><p>Additionally, two clusters indicate that some characteristics of RBCs are maintained only when they are suspended in autologous plasma. Control RBCs (CinC) show higher levels of pantothenol, which is known to have antiseptic properties (<xref ref-type="bibr" rid="bib47">Saliba et al., 2005</xref>), adenosine and hydroxyglutarate that were found decreased in hypoxia (<xref ref-type="bibr" rid="bib36">Nemkov et al., 2018</xref>), and formyl-kynurenine, probably buffering plasma kynurenine (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). In contrast, the most abundant proteins in patient RBCs (PinP) are linked to cellular responses to stress (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>), involving ubiquitination and protein degradation by the proteasome, which may be related to a higher oxidative stress. Increasing levels of guanidinoacetate, ornithine, urate, and L-citrulline indicate higher catabolism of arginine.</p><p>Since RBCs influence plasma metabolites and protein abundance, they must necessarily adapt their metabolism and protein content. Indeed, an effect occurs when RBCs are suspended in allogeneic plasma (CinP and PinC), resulting in changed levels of plasma proteins (ALB, FGA, FGB, GSN, TF, SERPINA1, SERPINC1) and immunoglobulin variables (IGHV439, IGHG2, IGKC) (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). These data indicate RBC acute ability to equilibrate their protein levels when coming in contact with new plasma, since the first cluster is comparable between CinC and PinP and between CinP and PinC (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). However, the changes in RBC metabolism and protein content that occur upon suspension with allogeneic plasma do not reflect RBC morphological changes, since PinP samples exhibit many more pathological RBC shapes than PinC samples.</p></sec></sec><sec id="s2-3"><title>Pathological RBC shapes are associated with markers of inflammation, oxidation, and hypoxia</title><sec id="s2-3-1"><title>RBC morphological correlations with plasma components</title><p>The main plasma components correlating with sphero-echinocytes are lactate and 2,3-diphospho-glycerate (2,3-DPG), associated to increased glycolysis; nicotinamide and tryptophanamide, related to tryptophan metabolism; glutamate, creatine, and hypoxanthine, which was previously found to be positively correlated with creatinine (<xref ref-type="bibr" rid="bib53">Thomas et al., 2020b</xref>); lactoferrin (LTF), an iron-binding protein with antimicrobial and anti-inflammatory activity (<xref ref-type="bibr" rid="bib12">Conneely, 2001</xref>); ectoine a compound associated to anti-inflammatory properties (<xref ref-type="bibr" rid="bib5">Bownik and Stępniewska, 2016</xref>) and found in COVID-19 sera, as well as 2-oxoglutarate (also known as <inline-formula><mml:math id="inf1"><mml:mi>α</mml:mi></mml:math></inline-formula>-ketoglutarate) (<xref ref-type="bibr" rid="bib23">Kaur et al., 2021</xref>; <xref ref-type="fig" rid="fig4">Figure 4C</xref>). The fraction of pathological cells also correlates to hypoxanthine, ectoine, and nicotinamide. TF levels negatively correlate to sphero-echinocyte percentage and fraction of pathological RBC shapes. TF was previously reported to decrease during COVID-19 infection (<xref ref-type="bibr" rid="bib11">Claise et al., 2022</xref>). Similarly, the levels of arginine and tyrosine were previously reported to negatively correlate with disease severity, as gleaned by the levels of the inflammatory cytokine interleukin-6 (IL-6) (<xref ref-type="bibr" rid="bib53">Thomas et al., 2020b</xref>). Analogously, decreases are observed in the levels of sulfur-containing amino acids, thiocysteine, 3-sufinoalanine, and cystine, a marker of redox homeostasis.</p></sec><sec id="s2-3-2"><title>RBC morphological correlations with RBC content</title><p>Most correlations to both sphero-echinocytes and the fraction of pathological RBC shapes are observed with respect to RBC content (<xref ref-type="fig" rid="fig4">Figure 4D</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Negative correlations result with lactate, in contrast with the positive correlation in plasma, and mannitol, for which decreased levels are associated with reduced deformability of RBCs (<xref ref-type="bibr" rid="bib6">Burke et al., 1981</xref>). Among the proteins is ALB, known to re-establish RBC discocyte shape in stored blood (<xref ref-type="bibr" rid="bib44">Reinhart et al., 2015</xref>) and TF, which is reduced in COVID-19 plasma and is correlated with increased levels of CRP and IL-6 (<xref ref-type="bibr" rid="bib11">Claise et al., 2022</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Tryptophan and the related metabolites formyl-kynurenine, kynurenine and serotonin negatively correlate with pathological RBC shapes, coherently with lower levels seen in patient RBCs (formyl-kynurenine, <xref ref-type="fig" rid="fig4">Figure 4C</xref>). Serotonin and dopamine result negatively correlated with the fraction of pathological RBC shapes. In contrast, positive correlations exist with several amino acids, such as methionine, tyrosine, lysine, histidine, threonine, and arginine catabolism products through the urea cycle, specifically citrulline, ornithine, arginine-succinate and urate. Creatine and creatinine levels also result positively correlated, further suggesting an enhanced arginine catabolism. These results highlight that RBC buffering activity to contrast the altered amino acid metabolism implies their morphological impairment. Finally, while formyl-kynurenine and kynurenine negatively correlate, positive correlations exist with anthranilate and picolinic acid, suggesting the ability of pathological RBCs to buffer kynurenine pathway metabolites. Positively correlated proteins are linked to different biological processes. Gas and ion transport-related proteins, such as carbonic anhydrase (CA2) and band3 (SLC4A1) are linked to pathological RBC shapes; a special highlight is a correlation with the expression of hemoglobin F subunits (HBG1 and HBG2). These data suggest a need to adjust oxygen transport, transporter activity, and pH buffering (chloride/bicarbonate ratios impact intracellular pH of RBCs) during the infection state (<xref ref-type="bibr" rid="bib36">Nemkov et al., 2018</xref>). Other correlations are found with several proteasome-linked proteins, such as PSMB2, PSMB6, PSMA1, PSMC4, PSMC2 (<xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>) with an ATP-dependent function, indicating high levels of protein degradation and regulation of amino acid metabolism in pathological RBCs. Indications of an enhanced antioxidant activity to cope with increased oxidative stress in such cells is highlighted by positive correlations with glutathione metabolism-related enzymes, such as glutathione S-transferase Mu 3 (GSTM3), glutathione reductase (GSR), which maintains reduced glutathione, and glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme for the pentose-phosphate pathway (PPP), which is the only source for NADPH generation in RBCs, thus the main pathway for protection against oxidative stress. In addition, a positive correlation exists with peroxiredoxin 1 (PRDX1) that catalyzes the reduction of hydrogen peroxide. Further correlations are found with nicotinamide-phosphoribosyl transferase (NAMPT), which catalyzes the biosynthesis of NAD, and NADH-cytochrome b5 reductase 3 (CYB5R3), which reduces methemoglobin, the oxidated form of hemoglobin to the ferric state.</p><p>Together, these data show that morphological impairments observed in RBCs flowing in COVID-19 patient plasma are strongly related to markers of inflammation, oxidation, and hypoxia, which are associated with increased mortality risk (<xref ref-type="bibr" rid="bib15">D’Alessandro et al., 2021b</xref>).</p></sec></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our microfluidic analysis demonstrates a significantly increased number of pathological RBC shapes, such as sphero-echinocytes in the capillary flow of COVID-19 patients (PinP) (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). These changes lead to an alteration of the microscale flow behavior since these RBCs are not able to adapt their shape to the imposed flow conditions compared to healthy controls (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Static images of the same suspensions confirm such morphological changes, where impaired RBCs can be visualized as sphero-echinocytes. Although patients show increased levels of fibrinogen (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>), which would favor an enhanced formation of RBC clusters (<xref ref-type="bibr" rid="bib16">Dasanna et al., 2022</xref>), their RBCs do not aggregate into rouleaux but form disorganized structures. Hence, we hypothesize that the severe alterations of RBC shapes and deformability hinder the formation of RBC aggregates in stasis. However, COVID-19 RBCs are able to revert their shape to biconcave disks in stasis and healthy croissant and slipper shapes in flow, resulting in a single-cell flow behavior comparable to control samples. Interestingly, the reversibility of sphero-echinocytes contradicts previous literature. Up to now, it was assumed that sphero-echinocytes cannot reverse to discocytes due to membrane loss through vesiculation that imbalances the structure of the lipid bilayer but this was not demonstrated mathematically (Lim H. W. et al., 2009). Marcel Bessis, one of the fathers of RBC classification based on their morphology, declared in his book ‘Red Cell Shape’ (<xref ref-type="bibr" rid="bib3">Bessis et al., 1973</xref>) that sphero-echinocytes are not reversible to discocytes, without providing an experimental proof. This belief became so ingrained that it has never been argued. However, in previous work (<xref ref-type="bibr" rid="bib39">Ponder, 1948</xref>), spherocytes, the very last transition stage of RBC before hemolysis, were described to be able to revert to biconcave disks as long as they have not reached the stage of prolytic spheres (<xref ref-type="bibr" rid="bib39">Ponder, 1948</xref>). Moreover, it has been recently shown that morphological alterations concomitant to membrane shedding and acquisition of a spheroechinocytic phenotype, though apparently reversible in the present study, would still give rise to smaller RBCs of decreased volumes, which are preferentially cleared from the bloodstream via splenic sequestration (<xref ref-type="bibr" rid="bib46">Roussel et al., 2021</xref>). Of note, echinocytes presence is not a specific feature of COVID-19 infection but has been previously observed in stasis in blood smears of septic patients (<xref ref-type="bibr" rid="bib1">Bateman et al., 2017</xref>).</p><p>Patient plasma results in increased levels of inflammation and hypercoagulation markers, in accordance with previously published data (<xref ref-type="bibr" rid="bib53">Thomas et al., 2020b</xref>). Particularly interesting due to its association with higher mortality risk is kynurenine, which decreases upon suspension of healthy control RBCs in COVID-19 plasma. Kynurenine levels are associated with hypoxia markers and interferon signaling (IFNG) (<xref ref-type="bibr" rid="bib15">D’Alessandro et al., 2021b</xref>; <xref ref-type="bibr" rid="bib19">Galbraith et al., 2022</xref>). The restoration of proteins and metabolites levels is acute and immediate and occurs at the expense of RBC shapes. Note that for the microfluidic experiments, RBCs must be diluted in control or patient plasma to obtain single-cell flow. This dilution could possibly impact the observed morphological changes of RBCs in patient plasma. With the used dilution, we see normal flow shapes for healthy RBC in autologous plasma, which are in agreement with previous studies in similar microchannels (<xref ref-type="bibr" rid="bib20">Guckenberger et al., 2018</xref>; <xref ref-type="bibr" rid="bib24">Kihm et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Recktenwald et al., 2022a</xref>; <xref ref-type="bibr" rid="bib43">Recktenwald et al., 2022b</xref>) and are therefore used as a basis to validate the chosen experimental setting. For the metabolomic and proteomic analyses, we use hematocrits close to the physiological ones. For these reasons, we believe that dilution is not a major reason for the described changes in RBCs and plasma in both types of samples (microfluidic and omics). The obtained results highlight a non-previously identified ‘sponge-like’ behavior of RBCs that is used to control plasma homeostasis. These influences and adaptations to the surrounding environment may be a specific feature of RBCs since they cannot synthesize new proteins and thus respond to needs through metabolic adjustments that also involve shape transformations. Proteomics and metabolomics data on RBCs indeed confirm that the differences between healthy and patient cells reflect the differences observed in their plasma content. A deeper investigation on morphologically impaired COVID-19 RBCs by correlation analysis results in their association with markers of inflammation, oxidation, and hypoxia in the plasma, features that act in a tight relation to overcome the infection.</p><p>Guanidinoacetate and ornithine correlations in patient RBCs suggest more activity of arginase that results in creatine production, which is used for ATP synthesis. It was previously seen that incubation of RBCs with arginine leads to the production of citrulline, ornithine, and urea, indicating an RBC-related enzymatic machinery for arginine metabolism (<xref ref-type="bibr" rid="bib41">Ramírez-Zamora et al., 2013</xref>). The functional role of increased arginine catabolism may be to increase nitric oxide (NO) availability to respond to hypoxia, inducing vasodilation for an increased blood flow. Arginine supplementation increases T-cell proliferation and macrophage activity, thus it could contribute to enhance immune response (<xref ref-type="bibr" rid="bib15">D’Alessandro et al., 2021b</xref>). As well, creatine leads to ATP synthesis, which increases during the immune response to boost leukocyte proliferation and activity. Moreover, tryptophan metabolism is involved in nicotinamide and NAD production. NAD is implicated in the glycolytic pathway and oxidative phosphorylation and its formation from tryptophan metabolism was demonstrated to boost macrophage phagocytic activity during immune response (<xref ref-type="bibr" rid="bib34">Minhas et al., 2019</xref>). Dopamine has a role in the initiation of immune responses in lymphocytes (<xref ref-type="bibr" rid="bib8">Buttarelli et al., 2011</xref>). The biosynthesis of serotonin and dopamine, which are negatively correlated with morphological RBC deviations, is thought to decrease in COVID-19 infection due to a co-expression and a functional link with Angiotensin I Converting Enzyme 2 (ACE2) (<xref ref-type="bibr" rid="bib35">Nataf, 2020</xref>), the main receptor for SARS-CoV-2. Together, these data highlight the relevance of RBC buffering effect for immune cell activity regulation.</p><p>Positive correlations with plasma lactate levels are also linked to increased energy demand. Hypoxia causes a boost in glycolysis to produce and release more ATP that stimulates NO production and vasodilation, as well as 2,3-DPG that increases deoxyhemoglobin release of oxygen (<xref ref-type="bibr" rid="bib36">Nemkov et al., 2018</xref>). ATP release also results in increased adenosine and xanthine in hypoxic plasma, as observed in our data. Adenosine levels remain high because PKA triggers a hypoxia-induced proteasome that degrades adenosine transporters (<xref ref-type="bibr" rid="bib36">Nemkov et al., 2018</xref>), as we show from the correlation with several proteasome ATP-dependent proteins. More glycolysis results in less PPP for glutathione reduction, so less NADPH formation and presumably less antioxidant capacity of RBCs. Although the oxygen dissociation curve was not found different in COVID-19 patients (<xref ref-type="bibr" rid="bib4">Böning et al., 2021</xref>) the presence of markers of hypoxia is expectable, considering that COVID-19 infection often results in lowered blood oxygen saturation, and in ECMO patients it is reduced until 82% (<xref ref-type="bibr" rid="bib48">Schmidt et al., 2013</xref>). A reason for no differences in the oxygen dissociation curve may be due to methemoglobin, which increases hemoglobin oxygen affinity and may compensate the opposite effect of 2,3-DPG (<xref ref-type="bibr" rid="bib4">Böning et al., 2021</xref>). Indeed, we found positive correlations with methemoglobin and hemoglobin F globin chains, whose expression is stimulated by hypoxia (<xref ref-type="bibr" rid="bib50">Simionato et al., 2022</xref>). This highlights an effect of the infectious state also at the level of erythropoiesis.</p><p>Sphero-echinocytes show increased antioxidant activity since they are positively correlated with GSR, which catalyzes glutathione reduction, G6PD that is necessary for NADPH formation, and PRDX1, which reduces hydroperoxides. This response is associated with the infectious state since in septic patients proinflammatory cytokines such as TNF alpha promote ROS generation to destroy bacteria (<xref ref-type="bibr" rid="bib1">Bateman et al., 2017</xref>). We could not find differences in, for example, levels of band 3 (AE1), to indicate oxidative stress-associated loss of cytoskeletal proteins, but it was reported oxidation of band 3, spectrin (SPTA1) and ankyrin (ANK1) (<xref ref-type="bibr" rid="bib52">Thomas et al., 2020a</xref>), which, along with alterations of the lipid compartments, may alter RBC deformability. We see that the impaired deformability in COVID-19 cells is mostly reversible, thus not indicating damaged antioxidant mechanisms in RBCs, but rather increased oxidative stress caused by higher ROS generation during the infection that may be resolved by increasing RBC antioxidant defense.</p><p>The results of our study create the basis for possible clinical impacts: convalescent plasma transfusion was shown not to be associated with improved clinical outcomes (<xref ref-type="bibr" rid="bib22">Janiaud et al., 2021</xref>). While plasma transfusions from healthy individuals may benefit RBC flow properties in COVID-19 patients that may potentially decrease RBC-related thrombotic risk (<xref ref-type="bibr" rid="bib9">Byrnes and Wolberg, 2017</xref>), patient antibodies would be diluted, possibly compromising the efficacy of the immune response to the virus. Although the observed severe changes in RBC shapes could potentially act as a starting point for clinical studies, it is unclear whether a plasma or erythrocyte concentrate (EC) transfusion will be beneficial. Therefore, further studies are necessary to evaluate the mechanisms through which RBCs re-establish plasma equilibria, potentially decreasing patient mortality risk.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Blood collection</title><p>Nine mL of blood is drawn in heparin tubes from five healthy volunteers under informed consent and 14 COVID-19 patients admitted at the Intensive Care Unit (ICU) at the Frankfurt University Hospital, seven of which with supported ventilation and six receiving extracorporeal membrane oxygenation (ECMO) (<xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). The study is performed according to the Declaration of Helsinki and under the approval of the local ethics committee (reference #20–643, #20–982). Healthy and patient blood tubes are transported at room temperature and processed after 2 hr from blood drawing.</p></sec><sec id="s4-2"><title>Sample preparation</title><p>Blood is leukodepleted (Pall’s Acrodisc PSF syringe filters, Pall Corporation, New York, NY) and centrifuged at 1500×g for 5 min to separate RBCs and plasma. RBCs are then suspended in PBS (Gibco PBS, Thermo Fisher, Bremen, Germany) and the centrifugation and washing steps are repeated three times. Plasma fraction is centrifuged at 5000×g for 5 min to assure the removal of platelets, then used to resuspend washed RBCs in autologous plasma at a final hematocrit of 0.5%. Additionally, patient RBCs are suspended in blood group-matching control plasma and control RBCs in patient plasma, obtaining four sample groups; (i) control RBCs in control plasma (CinC), (ii) patient RBCs in patient plasma (PinP), (iii) control RBCs in patient plasma (CinP), and (iv) patient RBCs in control plasma (PinC) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p></sec><sec id="s4-3"><title>Microfluidic setup</title><p>A microfluidic channel with a rectangular cross-section of 8 µm height (H) and 11 µm width (W) is used to pump RBC suspensions as described (<xref ref-type="bibr" rid="bib42">Recktenwald et al., 2022a</xref>). RBC flow x-y-plane is recorded with a frame rate of up to 400 fps using a pressure drop range between 100 mbar and 1000 mbar. The resulting cell velocities <inline-formula><mml:math id="inf2"><mml:mi>U</mml:mi></mml:math></inline-formula> are in the range of 0.7 mm s<sup>-1</sup> and 7 mm s<sup>-1</sup>, similar to the flow in the microvascular network (<xref ref-type="bibr" rid="bib40">Pries and Secomb, 2008</xref>; <xref ref-type="bibr" rid="bib49">Secomb, 2017</xref>). Based on these velocities, we estimate the wall shear rate as <inline-formula><mml:math id="inf3"><mml:mrow><mml:msub><mml:mover accent="true"><mml:mi>γ</mml:mi><mml:mo>˙</mml:mo></mml:mover><mml:mi>w</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>⁢</mml:mo><mml:mi>U</mml:mi></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mrow><mml:mi>H</mml:mi><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, which is in the range of approximately 350 s<sup>-1</sup> to 3500 s<sup>-1</sup>. This corresponds to a wall shear stress <inline-formula><mml:math id="inf4"><mml:msub><mml:mi>τ</mml:mi><mml:mi>w</mml:mi></mml:msub></mml:math></inline-formula> of 0.42 Pa to 4.2 Pa, based on a plasma viscosity of approximately <inline-formula><mml:math id="inf5"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>η</mml:mi><mml:mo>=</mml:mo><mml:mn>1.2</mml:mn><mml:mspace width="thinmathspace"/><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">s</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:math></inline-formula>.</p></sec><sec id="s4-4"><title>Flow analysis</title><p>Velocity, lateral cell position in the y-direction, and projection area of each cell are determined using a customized python script. Per patient/donor an average of 3317 individual cells (between 1199 and 5496 cells) are examined. Based on the RBC velocity, the distribution of RBC lateral y-position is used as a characteristic indicator of the single-cell flow in such confined microchannels (<xref ref-type="bibr" rid="bib24">Kihm et al., 2018</xref>; <xref ref-type="bibr" rid="bib20">Guckenberger et al., 2018</xref>; <xref ref-type="bibr" rid="bib42">Recktenwald et al., 2022a</xref>; <xref ref-type="bibr" rid="bib43">Recktenwald et al., 2022b</xref>). At a given mean velocity, the distribution of the absolute value of the cell lateral position in y-direction, normalized by the channel width, is determined and the corresponding probability density function (pdf) is calculated. At low velocities, RBCs preferentially form axisymmetric croissants that flow in the channel center, while slipper-shaped RBCs that emerge at higher velocities flow at an off-centered equilibrium position (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). We quantify the difference between pathological and healthy RBC flow by the so-called y-deviation, which relates the pdfs of the y-distributions of a given sample to the average distribution of healthy controls at specific cell velocities (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p><p>Additionally, we use a convolutional neural network (CNN) for a non-biased RBC shape analysis. The CNN consist of an image input layer, several subsequent convolution stages, and an output layer, as previously described (<xref ref-type="bibr" rid="bib24">Kihm et al., 2018</xref>; <xref ref-type="bibr" rid="bib43">Recktenwald et al., 2022b</xref>). The network is trained with 1000 representative images of each healthy and pathological shape (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>) that were manually classified before.</p></sec><sec id="s4-5"><title>Omics sample collection</title><p>Four hundred µL packed RBCs is suspended in 600 µL autologous or allogeneic compatible plasma for 20 min at 4°C resulting in a total sample volume of 1 mL with a hematocrit of 40%. Plasma is collected according to a modified Folch extraction method (<xref ref-type="bibr" rid="bib7">Burnum-Johnson et al., 2017</xref>) and the three fractions obtained (lipid, metabolite and protein-enriched) are stored in liquid nitrogen until analysis, as well as packed RBCs after suspension in autologous or allogeneic plasma. Samples are collected from three healthy controls and eight patients, of which four were with supported ventilation and four on ECMO.</p></sec><sec id="s4-6"><title>Ultra-high-pressure liquid chromatography-mass spectrometry (UHPLC-MS) metabolomics</title><p>A volume of 50 µL of frozen RBC aliquots is extracted in 950 µL methanol:acetonitrile:water (5:3:2, v/v/v). Samples are vortexed and insoluble material pelleted as described (<xref ref-type="bibr" rid="bib14">D’Alessandro et al., 2021a</xref>). Analyses are performed using a Vanquish UHPLC coupled online to a Q Exactive mass spectrometer (Thermo Fisher, Bremen, Germany). Samples are analyzed using a 3-min isocratic condition or a 5, 9, and 17 min gradient as described (<xref ref-type="bibr" rid="bib37">Nemkov et al., 2019</xref>). Solvents are supplemented with 0.1% formic acid for positive mode runs and 1 mM ammonium acetate for negative mode runs. MS acquisition, data analysis, and elaboration are performed as described (<xref ref-type="bibr" rid="bib37">Nemkov et al., 2019</xref>). Additional analyses, including untargeted analyses and Fish score calculation via MS/MS, are calculated against the ChemSpider database with Compound Discoverer 2.0 (Thermo Fisher, Bremen, Germany).</p></sec><sec id="s4-7"><title>Proteomics</title><p>Proteomics analyses are performed via filter aided sample preparation (FASP) digestion and nano UHPLC-MS/MS identification (TIMS TOF Pro 2 Single Cell Proteomics, Bruker Daltonics, Bremen, Germany), as previously described (<xref ref-type="bibr" rid="bib21">Issaian et al., 2021</xref>).</p></sec><sec id="s4-8"><title>Statistical analyses</title><p>Graphical representations and statistical analyses by T-test, repeated measures ANOVA or Kruskal-Wallis test are performed with GraphPad Prism (GraphPad Software, Inc, La Jolla, CA), MATLAB (MathWorks, Natick, MA), and MetaboAnalyst 5.0. Spearman’s rank correlation coefficient analysis is applied between the microfluidic and omics data. Both correlation data and omics raw data are included in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>Though unrelated to the contents of this manuscript, the authors declare that SMR, GS, LK, and SQ are co-founders of Cysmic GmbH</p></fn><fn fn-type="COI-statement" id="conf2"><p>Affiliated with Cysmic GmbH; the author has no financial interests to declare</p></fn><fn fn-type="COI-statement" id="conf3"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf4"><p>Though unrelated to the contents of this manuscript, AD is a founder of Omix Technologies Inc and Altis Biosciences LLC, and a scientific advisory board member for Hemanext Inc and Forma Therapeutics</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Resources, Writing – review and editing, Provided blood samples and clinical data interpretation</p></fn><fn fn-type="con" id="con7"><p>Resources, Writing – review and editing, Provided blood samples and clinical data interpretation</p></fn><fn fn-type="con" id="con8"><p>Resources, Writing – review and editing, Provided blood samples and clinical data interpretation</p></fn><fn fn-type="con" id="con9"><p>Resources, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Resources, Formal analysis, Supervision, Funding acquisition, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Supervision, Investigation, Methodology, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The study is performed according to the Declaration of Helsinki and under the approval of the local ethics committee (reference \#20-643, \#20-982) from five healthy volunteers and 14 COVID-19 patients under informed consent.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-81316-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files are provided for Figures 3 and 4.</p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No 860436 – EVIDENCE and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) in the framework of the research unit FOR 2688 ’Instabilities, Bifurcations and Migration in Pulsatile Flows’ WA 1336/13–1 and in the ’Open Access Publication Funding’ program with support by the Saarland University. We would like to thank Annett Wilken-Schmitz for the organizational support and collection of blood samples.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bateman</surname><given-names>RM</given-names></name><name><surname>Sharpe</surname><given-names>MD</given-names></name><name><surname>Singer</surname><given-names>M</given-names></name><name><surname>Ellis</surname><given-names>CG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The effect of sepsis on the erythrocyte</article-title><source>International Journal of Molecular Sciences</source><volume>18</volume><elocation-id>1932</elocation-id><pub-id pub-id-type="doi">10.3390/ijms18091932</pub-id><pub-id pub-id-type="pmid">28885563</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bernhardt</surname><given-names>I</given-names></name><name><surname>Ellory</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2013">2013</year><source>Red Cell Membrane Transport in Health and Disease</source><publisher-name>Springer Science &amp; Business Media</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-662-05181-8</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bessis</surname><given-names>MC</given-names></name><name><surname>Weed</surname><given-names>RI</given-names></name><name><surname>Leblond</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="1973">1973</year><source>Red Cell Shape</source><publisher-loc>Berlin, Heidelberg</publisher-loc><publisher-name>Springer</publisher-name><pub-id pub-id-type="doi">10.1007/978-3-642-88062-9</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Böning</surname><given-names>D</given-names></name><name><surname>Kuebler</surname><given-names>WM</given-names></name><name><surname>Bloch</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The oxygen dissociation curve of blood in covid-19</article-title><source>American Journal of Physiology. Lung Cellular and Molecular Physiology</source><volume>321</volume><fpage>L349</fpage><lpage>L357</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00079.2021</pub-id><pub-id pub-id-type="pmid">33978488</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bownik</surname><given-names>A</given-names></name><name><surname>Stępniewska</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Ectoine as a promising protective agent in humans and animals</article-title><source>Arhiv Za Higijenu Rada i Toksikologiju</source><volume>67</volume><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="doi">10.1515/aiht-2016-67-2837</pub-id><pub-id pub-id-type="pmid">28033102</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname><given-names>AM</given-names></name><name><surname>Quest</surname><given-names>DO</given-names></name><name><surname>Chien</surname><given-names>S</given-names></name><name><surname>Cerri</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>The effects of mannitol on blood viscosity</article-title><source>Journal of Neurosurgery</source><volume>55</volume><fpage>550</fpage><lpage>553</lpage><pub-id pub-id-type="doi">10.3171/jns.1981.55.4.0550</pub-id><pub-id pub-id-type="pmid">6792325</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burnum-Johnson</surname><given-names>KE</given-names></name><name><surname>Kyle</surname><given-names>JE</given-names></name><name><surname>Eisfeld</surname><given-names>AJ</given-names></name><name><surname>Casey</surname><given-names>CP</given-names></name><name><surname>Stratton</surname><given-names>KG</given-names></name><name><surname>Gonzalez</surname><given-names>JF</given-names></name><name><surname>Habyarimana</surname><given-names>F</given-names></name><name><surname>Negretti</surname><given-names>NM</given-names></name><name><surname>Sims</surname><given-names>AC</given-names></name><name><surname>Chauhan</surname><given-names>S</given-names></name><name><surname>Thackray</surname><given-names>LB</given-names></name><name><surname>Halfmann</surname><given-names>PJ</given-names></name><name><surname>Walters</surname><given-names>KB</given-names></name><name><surname>Kim</surname><given-names>Y-M</given-names></name><name><surname>Zink</surname><given-names>EM</given-names></name><name><surname>Nicora</surname><given-names>CD</given-names></name><name><surname>Weitz</surname><given-names>KK</given-names></name><name><surname>Webb-Robertson</surname><given-names>B-JM</given-names></name><name><surname>Nakayasu</surname><given-names>ES</given-names></name><name><surname>Ahmer</surname><given-names>B</given-names></name><name><surname>Konkel</surname><given-names>ME</given-names></name><name><surname>Motin</surname><given-names>V</given-names></name><name><surname>Baric</surname><given-names>RS</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><name><surname>Kawaoka</surname><given-names>Y</given-names></name><name><surname>Waters</surname><given-names>KM</given-names></name><name><surname>Smith</surname><given-names>RD</given-names></name><name><surname>Metz</surname><given-names>TO</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>MPLEx: a method for simultaneous pathogen inactivation and extraction of samples for multi-OMICS profiling</article-title><source>The Analyst</source><volume>142</volume><fpage>442</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1039/c6an02486f</pub-id><pub-id pub-id-type="pmid">28091625</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buttarelli</surname><given-names>FR</given-names></name><name><surname>Fanciulli</surname><given-names>A</given-names></name><name><surname>Pellicano</surname><given-names>C</given-names></name><name><surname>Pontieri</surname><given-names>FE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders</article-title><source>Current Neuropharmacology</source><volume>9</volume><fpage>278</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.2174/157015911795596612</pub-id><pub-id pub-id-type="pmid">22131937</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrnes</surname><given-names>JR</given-names></name><name><surname>Wolberg</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Red blood cells in thrombosis</article-title><source>Blood</source><volume>130</volume><fpage>1795</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1182/blood-2017-03-745349</pub-id><pub-id pub-id-type="pmid">28811305</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruso</surname><given-names>C</given-names></name><name><surname>Fay</surname><given-names>ME</given-names></name><name><surname>Cheng</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>AY</given-names></name><name><surname>Park</surname><given-names>SI</given-names></name><name><surname>Sulchek</surname><given-names>TA</given-names></name><name><surname>Graham</surname><given-names>MD</given-names></name><name><surname>Lam</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pathologic mechanobiological interactions between red blood cells and endothelial cells directly induce vasculopathy in iron deficiency anemia</article-title><source>IScience</source><volume>25</volume><elocation-id>104606</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2022.104606</pub-id><pub-id pub-id-type="pmid">35800766</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claise</surname><given-names>C</given-names></name><name><surname>Saleh</surname><given-names>J</given-names></name><name><surname>Rezek</surname><given-names>M</given-names></name><name><surname>Vaulont</surname><given-names>S</given-names></name><name><surname>Peyssonnaux</surname><given-names>C</given-names></name><name><surname>Edeas</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Low transferrin levels predict heightened inflammation in patients with covid-19: new insights</article-title><source>International Journal of Infectious Diseases</source><volume>116</volume><fpage>74</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.ijid.2021.12.340</pub-id><pub-id pub-id-type="pmid">34952211</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conneely</surname><given-names>OM</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Antiinflammatory activities of lactoferrin</article-title><source>Journal of the American College of Nutrition</source><volume>20</volume><fpage>389S</fpage><lpage>395S</lpage><pub-id pub-id-type="doi">10.1080/07315724.2001.10719173</pub-id><pub-id pub-id-type="pmid">11603648</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Alessandro</surname><given-names>A</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Dzieciatkowska</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>RC</given-names></name><name><surname>Francis</surname><given-names>RO</given-names></name><name><surname>Hudson</surname><given-names>KE</given-names></name><name><surname>Zimring</surname><given-names>JC</given-names></name><name><surname>Hod</surname><given-names>EA</given-names></name><name><surname>Spitalnik</surname><given-names>SL</given-names></name><name><surname>Hansen</surname><given-names>KC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level</article-title><source>Journal of Proteome Research</source><volume>19</volume><fpage>4417</fpage><lpage>4427</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.0c00365</pub-id><pub-id pub-id-type="pmid">32786691</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Alessandro</surname><given-names>A</given-names></name><name><surname>Akpan</surname><given-names>I</given-names></name><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Reisz</surname><given-names>J</given-names></name><name><surname>Cendali</surname><given-names>F</given-names></name><name><surname>Gamboni</surname><given-names>F</given-names></name><name><surname>Nemkov</surname><given-names>T</given-names></name><name><surname>Thangaraju</surname><given-names>K</given-names></name><name><surname>Katneni</surname><given-names>U</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Kahn</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>A</given-names></name><name><surname>Valk</surname><given-names>J</given-names></name><name><surname>Hudson</surname><given-names>K</given-names></name><name><surname>Roh</surname><given-names>D</given-names></name><name><surname>Moriconi</surname><given-names>C</given-names></name><name><surname>Zimring</surname><given-names>J</given-names></name><name><surname>Hod</surname><given-names>E</given-names></name><name><surname>Spitalnik</surname><given-names>S</given-names></name><name><surname>Buehler</surname><given-names>P</given-names></name><name><surname>Francis</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Biological and clinical factors contributing to the metabolic heterogeneity of hospitalized patients with and without covid-19</article-title><source>Research Square</source><volume>10</volume><elocation-id>rs.3.rs-480167</elocation-id><pub-id pub-id-type="doi">10.21203/rs.3.rs-480167/v1</pub-id><pub-id pub-id-type="pmid">34013258</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Alessandro</surname><given-names>A</given-names></name><name><surname>Fu</surname><given-names>X</given-names></name><name><surname>Kanias</surname><given-names>T</given-names></name><name><surname>Reisz</surname><given-names>JA</given-names></name><name><surname>Culp-Hill</surname><given-names>R</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Gladwin</surname><given-names>MT</given-names></name><name><surname>Page</surname><given-names>G</given-names></name><name><surname>Kleinman</surname><given-names>S</given-names></name><name><surname>Lanteri</surname><given-names>M</given-names></name><name><surname>Stone</surname><given-names>M</given-names></name><name><surname>Busch</surname><given-names>MP</given-names></name><name><surname>Zimring</surname><given-names>JC</given-names></name><collab>Recipient Epidemiology and Donor Evaluation Study-III REDS III</collab></person-group><year iso-8601-date="2021">2021b</year><article-title>Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity</article-title><source>Haematologica</source><volume>106</volume><fpage>1290</fpage><lpage>1302</lpage><pub-id pub-id-type="doi">10.3324/haematol.2020.246603</pub-id><pub-id pub-id-type="pmid">32241843</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasanna</surname><given-names>AK</given-names></name><name><surname>Darras</surname><given-names>A</given-names></name><name><surname>John</surname><given-names>T</given-names></name><name><surname>Gompper</surname><given-names>G</given-names></name><name><surname>Kaestner</surname><given-names>L</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name><name><surname>Fedosov</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Erythrocyte sedimentation: effect of aggregation energy on gel structure during collapse</article-title><source>Physical Review. E</source><volume>105</volume><elocation-id>024610</elocation-id><pub-id pub-id-type="doi">10.1103/PhysRevE.105.024610</pub-id><pub-id pub-id-type="pmid">35291110</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Della Rocca</surname><given-names>DG</given-names></name><name><surname>Magnocavallo</surname><given-names>M</given-names></name><name><surname>Lavalle</surname><given-names>C</given-names></name><name><surname>Romero</surname><given-names>J</given-names></name><name><surname>Forleo</surname><given-names>GB</given-names></name><name><surname>Tarantino</surname><given-names>N</given-names></name><name><surname>Chimenti</surname><given-names>C</given-names></name><name><surname>Alviz</surname><given-names>I</given-names></name><name><surname>Gamero</surname><given-names>MT</given-names></name><name><surname>Garcia</surname><given-names>MJ</given-names></name><name><surname>Di Biase</surname><given-names>L</given-names></name><name><surname>Natale</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evidence of systemic endothelial injury and microthrombosis in hospitalized COVID-19 patients at different stages of the disease</article-title><source>Journal of Thrombosis and Thrombolysis</source><volume>51</volume><fpage>571</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1007/s11239-020-02330-1</pub-id><pub-id pub-id-type="pmid">33156441</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Carlo</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A mechanical biomarker of cell state in medicine</article-title><source>Journal of Laboratory Automation</source><volume>17</volume><fpage>32</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1177/2211068211431630</pub-id><pub-id pub-id-type="pmid">22357606</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galbraith</surname><given-names>MD</given-names></name><name><surname>Kinning</surname><given-names>KT</given-names></name><name><surname>Sullivan</surname><given-names>KD</given-names></name><name><surname>Araya</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>KP</given-names></name><name><surname>Granrath</surname><given-names>RE</given-names></name><name><surname>Shaw</surname><given-names>JR</given-names></name><name><surname>Baxter</surname><given-names>R</given-names></name><name><surname>Jordan</surname><given-names>KR</given-names></name><name><surname>Russell</surname><given-names>S</given-names></name><name><surname>Dzieciatkowska</surname><given-names>M</given-names></name><name><surname>Reisz</surname><given-names>JA</given-names></name><name><surname>Gamboni</surname><given-names>F</given-names></name><name><surname>Cendali</surname><given-names>F</given-names></name><name><surname>Ghosh</surname><given-names>T</given-names></name><name><surname>Guo</surname><given-names>K</given-names></name><name><surname>Wilson</surname><given-names>CC</given-names></name><name><surname>Santiago</surname><given-names>ML</given-names></name><name><surname>Monte</surname><given-names>AA</given-names></name><name><surname>Bennett</surname><given-names>TD</given-names></name><name><surname>Hansen</surname><given-names>KC</given-names></name><name><surname>Hsieh</surname><given-names>EWY</given-names></name><name><surname>D’Alessandro</surname><given-names>A</given-names></name><name><surname>Espinosa</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Specialized interferon action in covid-19</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2116730119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2116730119</pub-id><pub-id pub-id-type="pmid">35217532</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guckenberger</surname><given-names>A</given-names></name><name><surname>Kihm</surname><given-names>A</given-names></name><name><surname>John</surname><given-names>T</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name><name><surname>Gekle</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Numerical-experimental observation of shape bistability of red blood cells flowing in a microchannel</article-title><source>Soft Matter</source><volume>14</volume><fpage>2032</fpage><lpage>2043</lpage><pub-id pub-id-type="doi">10.1039/c7sm02272g</pub-id><pub-id pub-id-type="pmid">29473072</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Issaian</surname><given-names>A</given-names></name><name><surname>Hay</surname><given-names>A</given-names></name><name><surname>Dzieciatkowska</surname><given-names>M</given-names></name><name><surname>Roberti</surname><given-names>D</given-names></name><name><surname>Perrotta</surname><given-names>S</given-names></name><name><surname>Darula</surname><given-names>Z</given-names></name><name><surname>Redzic</surname><given-names>J</given-names></name><name><surname>Busch</surname><given-names>MP</given-names></name><name><surname>Page</surname><given-names>GP</given-names></name><name><surname>Rogers</surname><given-names>SC</given-names></name><name><surname>Doctor</surname><given-names>A</given-names></name><name><surname>Hansen</surname><given-names>KC</given-names></name><name><surname>Eisenmesser</surname><given-names>EZ</given-names></name><name><surname>Zimring</surname><given-names>JC</given-names></name><name><surname>D’Alessandro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The interactome of the N-terminus of band 3 regulates red blood cell metabolism and storage quality</article-title><source>Haematologica</source><volume>106</volume><fpage>2971</fpage><lpage>2985</lpage><pub-id pub-id-type="doi">10.3324/haematol.2020.278252</pub-id><pub-id pub-id-type="pmid">33979990</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janiaud</surname><given-names>P</given-names></name><name><surname>Axfors</surname><given-names>C</given-names></name><name><surname>Schmitt</surname><given-names>AM</given-names></name><name><surname>Gloy</surname><given-names>V</given-names></name><name><surname>Ebrahimi</surname><given-names>F</given-names></name><name><surname>Hepprich</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>ER</given-names></name><name><surname>Haber</surname><given-names>NA</given-names></name><name><surname>Khanna</surname><given-names>N</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Goodman</surname><given-names>SN</given-names></name><name><surname>Ioannidis</surname><given-names>JPA</given-names></name><name><surname>Hemkens</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Association of convalescent plasma treatment with clinical outcomes in patients with covid-19: a systematic review and meta-analysis</article-title><source>JAMA</source><volume>325</volume><fpage>1185</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.2747</pub-id><pub-id pub-id-type="pmid">33635310</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>G</given-names></name><name><surname>Ji</surname><given-names>X</given-names></name><name><surname>Rahman</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>SARS-cov2 infection alters tryptophan catabolism and phospholipid metabolism</article-title><source>Metabolites</source><volume>11</volume><elocation-id>659</elocation-id><pub-id pub-id-type="doi">10.3390/metabo11100659</pub-id><pub-id pub-id-type="pmid">34677374</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kihm</surname><given-names>A</given-names></name><name><surname>Kaestner</surname><given-names>L</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name><name><surname>Quint</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Classification of red blood cell shapes in flow using outlier tolerant machine learning</article-title><source>PLOS Computational Biology</source><volume>14</volume><elocation-id>e1006278</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1006278</pub-id><pub-id pub-id-type="pmid">29906283</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubánková</surname><given-names>M</given-names></name><name><surname>Hohberger</surname><given-names>B</given-names></name><name><surname>Hoffmanns</surname><given-names>J</given-names></name><name><surname>Fürst</surname><given-names>J</given-names></name><name><surname>Herrmann</surname><given-names>M</given-names></name><name><surname>Guck</surname><given-names>J</given-names></name><name><surname>Kräter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Physical phenotype of blood cells is altered in COVID-19</article-title><source>Biophysical Journal</source><volume>120</volume><fpage>2838</fpage><lpage>2847</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2021.05.025</pub-id><pub-id pub-id-type="pmid">34087216</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanotte</surname><given-names>L</given-names></name><name><surname>Mauer</surname><given-names>J</given-names></name><name><surname>Mendez</surname><given-names>S</given-names></name><name><surname>Fedosov</surname><given-names>DA</given-names></name><name><surname>Fromental</surname><given-names>JMM</given-names></name><name><surname>Claveria</surname><given-names>V</given-names></name><name><surname>Nicoud</surname><given-names>F</given-names></name><name><surname>Gompper</surname><given-names>G</given-names></name><name><surname>Abkarian</surname><given-names>M</given-names></name><name><surname>Mauer</surname><given-names>J</given-names></name><name><surname>Fedosov</surname><given-names>DA</given-names></name><name><surname>Gompper</surname><given-names>G</given-names></name><name><surname>Mendez</surname><given-names>S</given-names></name><name><surname>Nicoud</surname><given-names>F</given-names></name><name><surname>Fromental</surname><given-names>JMM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Red cells’ dynamic morphologies govern blood shear thinning under microcirculatory flow conditions</article-title><source>PNAS</source><volume>113</volume><fpage>13289</fpage><lpage>13294</lpage><pub-id pub-id-type="doi">10.1073/pnas.1608074113</pub-id><pub-id pub-id-type="pmid">27834220</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2009">2009</year><source>Red Blood Cell Shapes and Shape Transformations: Newtonian Mechanics of a Composite Membrane: Sections 2.5–2.8, Chapter 2</source><publisher-name>Wiley-VCH Verlag GmbH &amp; Co. KGaA</publisher-name></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipowsky</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Microvascular rheology and hemodynamics</article-title><source>Microcirculation</source><volume>12</volume><fpage>5</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1080/10739680590894966</pub-id><pub-id pub-id-type="pmid">15804970</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangge</surname><given-names>H</given-names></name><name><surname>Herrmann</surname><given-names>M</given-names></name><name><surname>Meinitzer</surname><given-names>A</given-names></name><name><surname>Pailer</surname><given-names>S</given-names></name><name><surname>Curcic</surname><given-names>P</given-names></name><name><surname>Sloup</surname><given-names>Z</given-names></name><name><surname>Holter</surname><given-names>M</given-names></name><name><surname>Prüller</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Increased kynurenine indicates a fatal course of COVID-19</article-title><source>Antioxidants</source><volume>10</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.3390/antiox10121960</pub-id><pub-id pub-id-type="pmid">34943063</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Mann</surname><given-names>ER</given-names></name><name><surname>Menon</surname><given-names>M</given-names></name><name><surname>Knight</surname><given-names>SB</given-names></name><name><surname>Konkel</surname><given-names>JE</given-names></name><name><surname>Jagger</surname><given-names>C</given-names></name><name><surname>Shaw</surname><given-names>TN</given-names></name><name><surname>Krishnan</surname><given-names>S</given-names></name><name><surname>Rattray</surname><given-names>M</given-names></name><name><surname>Ustianowski</surname><given-names>A</given-names></name><name><surname>Bakerly</surname><given-names>ND</given-names></name><name><surname>Dark</surname><given-names>P</given-names></name><name><surname>Lord</surname><given-names>G</given-names></name><name><surname>Simpson</surname><given-names>A</given-names></name><name><surname>Felton</surname><given-names>T</given-names></name><name><surname>Ho</surname><given-names>LP</given-names></name><name><surname>Feldmann</surname><given-names>M</given-names></name><name><surname>Grainger</surname><given-names>JR</given-names></name><name><surname>Hussell</surname><given-names>T</given-names></name><collab>Respiratory TRC</collab><collab>CIRCO</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Longitudinal Immune Profiling Reveals Distinct Features of COVID-19 Pathogenesis</article-title><source>medRxiv</source><pub-id pub-id-type="doi">10.1101/2020.06.13.20127605</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname><given-names>K</given-names></name><name><surname>Myrand-Lapierre</surname><given-names>ME</given-names></name><name><surname>Ang</surname><given-names>RR</given-names></name><name><surname>Duffy</surname><given-names>SP</given-names></name><name><surname>Scott</surname><given-names>MD</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Microfluidic deformability analysis of the red cell storage lesion</article-title><source>Journal of Biomechanics</source><volume>48</volume><fpage>4065</fpage><lpage>4072</lpage><pub-id pub-id-type="doi">10.1016/j.jbiomech.2015.10.002</pub-id><pub-id pub-id-type="pmid">26477408</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname><given-names>P</given-names></name><name><surname>McAuley</surname><given-names>DF</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Sanchez</surname><given-names>E</given-names></name><name><surname>Tattersall</surname><given-names>RS</given-names></name><name><surname>Manson</surname><given-names>JJ</given-names></name><collab>HLH Across Speciality Collaboration, UK</collab></person-group><year iso-8601-date="2020">2020</year><article-title>COVID-19: consider cytokine storm syndromes and immunosuppression</article-title><source>Lancet</source><volume>395</volume><fpage>1033</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30628-0</pub-id><pub-id pub-id-type="pmid">32192578</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messner</surname><given-names>CB</given-names></name><name><surname>Demichev</surname><given-names>V</given-names></name><name><surname>Wendisch</surname><given-names>D</given-names></name><name><surname>Michalick</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>M</given-names></name><name><surname>Freiwald</surname><given-names>A</given-names></name><name><surname>Textoris-Taube</surname><given-names>K</given-names></name><name><surname>Vernardis</surname><given-names>SI</given-names></name><name><surname>Egger</surname><given-names>AS</given-names></name><name><surname>Kreidl</surname><given-names>M</given-names></name><name><surname>Ludwig</surname><given-names>D</given-names></name><name><surname>Kilian</surname><given-names>C</given-names></name><name><surname>Agostini</surname><given-names>F</given-names></name><name><surname>Zelezniak</surname><given-names>A</given-names></name><name><surname>Thibeault</surname><given-names>C</given-names></name><name><surname>Pfeiffer</surname><given-names>M</given-names></name><name><surname>Hippenstiel</surname><given-names>S</given-names></name><name><surname>Hocke</surname><given-names>A</given-names></name><name><surname>von Kalle</surname><given-names>C</given-names></name><name><surname>Campbell</surname><given-names>A</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Porteous</surname><given-names>DJ</given-names></name><name><surname>Marioni</surname><given-names>RE</given-names></name><name><surname>Langenberg</surname><given-names>C</given-names></name><name><surname>Lilley</surname><given-names>KS</given-names></name><name><surname>Kuebler</surname><given-names>WM</given-names></name><name><surname>Mülleder</surname><given-names>M</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Suttorp</surname><given-names>N</given-names></name><name><surname>Witzenrath</surname><given-names>M</given-names></name><name><surname>Kurth</surname><given-names>F</given-names></name><name><surname>Sander</surname><given-names>LE</given-names></name><name><surname>Ralser</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Ultra-high-throughput clinical proteomics reveals classifiers of covid-19 infection</article-title><source>Cell Systems</source><volume>11</volume><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.cels.2020.05.012</pub-id><pub-id pub-id-type="pmid">32619549</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minhas</surname><given-names>PS</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Moon</surname><given-names>PK</given-names></name><name><surname>Joshi</surname><given-names>AU</given-names></name><name><surname>Dove</surname><given-names>C</given-names></name><name><surname>Mhatre</surname><given-names>S</given-names></name><name><surname>Contrepois</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Lee</surname><given-names>BA</given-names></name><name><surname>Coronado</surname><given-names>M</given-names></name><name><surname>Bernstein</surname><given-names>D</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name><name><surname>Migaud</surname><given-names>M</given-names></name><name><surname>Majeti</surname><given-names>R</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name><name><surname>Andreasson</surname><given-names>KI</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation</article-title><source>Nature Immunology</source><volume>20</volume><fpage>50</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/s41590-018-0255-3</pub-id><pub-id pub-id-type="pmid">30478397</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nataf</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of covid-19</article-title><source>Journal of Medical Virology</source><volume>92</volume><fpage>1743</fpage><lpage>1744</lpage><pub-id pub-id-type="doi">10.1002/jmv.25826</pub-id><pub-id pub-id-type="pmid">32246784</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemkov</surname><given-names>T</given-names></name><name><surname>Reisz</surname><given-names>JA</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Zimring</surname><given-names>JC</given-names></name><name><surname>D’Alessandro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Red blood cells as an organ? how deep omics characterization of the most abundant cell in the human body highlights other systemic metabolic functions beyond oxygen transport</article-title><source>Expert Review of Proteomics</source><volume>15</volume><fpage>855</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1080/14789450.2018.1531710</pub-id><pub-id pub-id-type="pmid">30278801</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nemkov</surname><given-names>T</given-names></name><name><surname>Reisz</surname><given-names>JA</given-names></name><name><surname>Gehrke</surname><given-names>S</given-names></name><name><surname>Hansen</surname><given-names>KC</given-names></name><name><surname>D’Alessandro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><chapter-title>High-throughput metabolomics: isocratic and gradient mass spectrometry-based methods</chapter-title><person-group person-group-type="editor"><name><surname>Nemkov</surname><given-names>JA</given-names></name></person-group><source>High-Throughput Metabolomics</source><publisher-name>Springer</publisher-name><fpage>13</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9236-2_2</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piety</surname><given-names>NZ</given-names></name><name><surname>Stutz</surname><given-names>J</given-names></name><name><surname>Yilmaz</surname><given-names>N</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Shevkoplyas</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Microfluidic capillary networks are more sensitive than ektacytometry to the decline of red blood cell deformability induced by storage</article-title><source>Scientific Reports</source><volume>11</volume><elocation-id>604</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-79710-3</pub-id><pub-id pub-id-type="pmid">33436749</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ponder</surname><given-names>E</given-names></name></person-group><year iso-8601-date="1948">1948</year><source>Hemolysis and Related Phenomena</source><publisher-name>Saunders</publisher-name></element-citation></ref><ref id="bib40"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pries</surname><given-names>AR</given-names></name><name><surname>Secomb</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="2008">2008</year><chapter-title>Blood flow in microvascular networks</chapter-title><person-group person-group-type="editor"><name><surname>Pries</surname><given-names>AR</given-names></name></person-group><source>Microcirculation</source><publisher-name>Elsevier</publisher-name><fpage>3</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-374530-9.00001-2</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramírez-Zamora</surname><given-names>S</given-names></name><name><surname>Méndez-Rodríguez</surname><given-names>ML</given-names></name><name><surname>Olguín-Martínez</surname><given-names>M</given-names></name><name><surname>Sánchez-Sevilla</surname><given-names>L</given-names></name><name><surname>Quintana-Quintana</surname><given-names>M</given-names></name><name><surname>García-García</surname><given-names>N</given-names></name><name><surname>Hernández-Muñoz</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Increased erythrocytes by-products of arginine catabolism are associated with hyperglycemia and could be involved in the pathogenesis of type 2 diabetes mellitus</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e66823</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0066823</pub-id><pub-id pub-id-type="pmid">23826148</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recktenwald</surname><given-names>SM</given-names></name><name><surname>Graessel</surname><given-names>K</given-names></name><name><surname>Maurer</surname><given-names>FM</given-names></name><name><surname>John</surname><given-names>T</given-names></name><name><surname>Gekle</surname><given-names>S</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Red blood cell shape transitions and dynamics in time-dependent capillary flows</article-title><source>Biophysical Journal</source><volume>121</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2021.12.009</pub-id><pub-id pub-id-type="pmid">34896369</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Recktenwald</surname><given-names>SM</given-names></name><name><surname>Lopes</surname><given-names>MGM</given-names></name><name><surname>Peter</surname><given-names>S</given-names></name><name><surname>Hof</surname><given-names>S</given-names></name><name><surname>Simionato</surname><given-names>G</given-names></name><name><surname>Peikert</surname><given-names>K</given-names></name><name><surname>Hermann</surname><given-names>A</given-names></name><name><surname>Danek</surname><given-names>A</given-names></name><name><surname>van Bentum</surname><given-names>K</given-names></name><name><surname>Eichler</surname><given-names>H</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name><name><surname>Quint</surname><given-names>S</given-names></name><name><surname>Kaestner</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Erysense, a lab-on-a-chip-based point-of-care device to evaluate red blood cell flow properties with multiple clinical applications</article-title><source>Frontiers in Physiology</source><volume>13</volume><elocation-id>884690</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2022.884690</pub-id><pub-id pub-id-type="pmid">35574449</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhart</surname><given-names>WH</given-names></name><name><surname>Piety</surname><given-names>NZ</given-names></name><name><surname>Deuel</surname><given-names>JW</given-names></name><name><surname>Makhro</surname><given-names>A</given-names></name><name><surname>Schulzki</surname><given-names>T</given-names></name><name><surname>Bogdanov</surname><given-names>N</given-names></name><name><surname>Goede</surname><given-names>JS</given-names></name><name><surname>Bogdanova</surname><given-names>A</given-names></name><name><surname>Abidi</surname><given-names>R</given-names></name><name><surname>Shevkoplyas</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Washing stored red blood cells in an albumin solution improves their morphologic and hemorheologic properties</article-title><source>Transfusion</source><volume>55</volume><fpage>1872</fpage><lpage>1881</lpage><pub-id pub-id-type="doi">10.1111/trf.13052</pub-id><pub-id pub-id-type="pmid">25752902</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renoux</surname><given-names>C</given-names></name><name><surname>Fort</surname><given-names>R</given-names></name><name><surname>Nader</surname><given-names>E</given-names></name><name><surname>Boisson</surname><given-names>C</given-names></name><name><surname>Joly</surname><given-names>P</given-names></name><name><surname>Stauffer</surname><given-names>E</given-names></name><name><surname>Robert</surname><given-names>M</given-names></name><name><surname>Girard</surname><given-names>S</given-names></name><name><surname>Cibiel</surname><given-names>A</given-names></name><name><surname>Gauthier</surname><given-names>A</given-names></name><name><surname>Connes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Impact of covid-19 on red blood cell rheology</article-title><source>British Journal of Haematology</source><volume>192</volume><fpage>e108</fpage><lpage>e111</lpage><pub-id pub-id-type="doi">10.1111/bjh.17306</pub-id><pub-id pub-id-type="pmid">33410504</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roussel</surname><given-names>C</given-names></name><name><surname>Morel</surname><given-names>A</given-names></name><name><surname>Dussiot</surname><given-names>M</given-names></name><name><surname>Marin</surname><given-names>M</given-names></name><name><surname>Colard</surname><given-names>M</given-names></name><name><surname>Fricot-Monsinjon</surname><given-names>A</given-names></name><name><surname>Martinez</surname><given-names>A</given-names></name><name><surname>Chambrion</surname><given-names>C</given-names></name><name><surname>Henry</surname><given-names>B</given-names></name><name><surname>Casimir</surname><given-names>M</given-names></name><name><surname>Volle</surname><given-names>G</given-names></name><name><surname>Dépond</surname><given-names>M</given-names></name><name><surname>Dokmak</surname><given-names>S</given-names></name><name><surname>Paye</surname><given-names>F</given-names></name><name><surname>Sauvanet</surname><given-names>A</given-names></name><name><surname>Le Van Kim</surname><given-names>C</given-names></name><name><surname>Colin</surname><given-names>Y</given-names></name><name><surname>Georgeault</surname><given-names>S</given-names></name><name><surname>Roingeard</surname><given-names>P</given-names></name><name><surname>Spitalnik</surname><given-names>SL</given-names></name><name><surname>Ndour</surname><given-names>PA</given-names></name><name><surname>Hermine</surname><given-names>O</given-names></name><name><surname>Hod</surname><given-names>EA</given-names></name><name><surname>Buffet</surname><given-names>PA</given-names></name><name><surname>Amireault</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Rapid clearance of storage-induced microerythrocytes alters transfusion recovery</article-title><source>Blood</source><volume>137</volume><fpage>2285</fpage><lpage>2298</lpage><pub-id pub-id-type="doi">10.1182/blood.2020008563</pub-id><pub-id pub-id-type="pmid">33657208</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saliba</surname><given-names>KJ</given-names></name><name><surname>Ferru</surname><given-names>I</given-names></name><name><surname>Kirk</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Provitamin b5 (pantothenol) inhibits growth of the intraerythrocytic malaria parasite</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>49</volume><fpage>632</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.2.632-637.2005</pub-id><pub-id pub-id-type="pmid">15673744</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>M</given-names></name><name><surname>Tachon</surname><given-names>G</given-names></name><name><surname>Devilliers</surname><given-names>C</given-names></name><name><surname>Muller</surname><given-names>G</given-names></name><name><surname>Hekimian</surname><given-names>G</given-names></name><name><surname>Bréchot</surname><given-names>N</given-names></name><name><surname>Merceron</surname><given-names>S</given-names></name><name><surname>Luyt</surname><given-names>CE</given-names></name><name><surname>Trouillet</surname><given-names>J-L</given-names></name><name><surname>Chastre</surname><given-names>J</given-names></name><name><surname>Leprince</surname><given-names>P</given-names></name><name><surname>Combes</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults</article-title><source>Intensive Care Medicine</source><volume>39</volume><fpage>838</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1007/s00134-012-2785-8</pub-id><pub-id pub-id-type="pmid">23291732</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Secomb</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Blood flow in the microcirculation</article-title><source>Annual Review of Fluid Mechanics</source><volume>49</volume><fpage>443</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1146/annurev-fluid-010816-060302</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simionato</surname><given-names>G</given-names></name><name><surname>Rabe</surname><given-names>A</given-names></name><name><surname>Gallego-Murillo</surname><given-names>JS</given-names></name><name><surname>van der Zwaan</surname><given-names>C</given-names></name><name><surname>Hoogendijk</surname><given-names>AJ</given-names></name><name><surname>van den Biggelaar</surname><given-names>M</given-names></name><name><surname>Minetti</surname><given-names>G</given-names></name><name><surname>Bogdanova</surname><given-names>A</given-names></name><name><surname>Mairbäurl</surname><given-names>H</given-names></name><name><surname>Wagner</surname><given-names>C</given-names></name><name><surname>Kaestner</surname><given-names>L</given-names></name><name><surname>van den Akker</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>In vitro erythropoiesis at different PO2 induces adaptations that are independent of prior systemic exposure to hypoxia</article-title><source>Cells</source><volume>11</volume><elocation-id>1082</elocation-id><pub-id pub-id-type="doi">10.3390/cells11071082</pub-id><pub-id pub-id-type="pmid">35406648</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia</article-title><source>Journal of Thrombosis and Haemostasis</source><volume>18</volume><fpage>844</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1111/jth.14768</pub-id><pub-id pub-id-type="pmid">32073213</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Stefanoni</surname><given-names>D</given-names></name><name><surname>Dzieciatkowska</surname><given-names>M</given-names></name><name><surname>Issaian</surname><given-names>A</given-names></name><name><surname>Nemkov</surname><given-names>T</given-names></name><name><surname>Hill</surname><given-names>RC</given-names></name><name><surname>Francis</surname><given-names>RO</given-names></name><name><surname>Hudson</surname><given-names>KE</given-names></name><name><surname>Buehler</surname><given-names>PW</given-names></name><name><surname>Zimring</surname><given-names>JC</given-names></name><name><surname>Hod</surname><given-names>EA</given-names></name><name><surname>Hansen</surname><given-names>KC</given-names></name><name><surname>Spitalnik</surname><given-names>SL</given-names></name><name><surname>D’Alessandro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients</article-title><source>Journal of Proteome Research</source><volume>19</volume><fpage>4455</fpage><lpage>4469</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.0c00606</pub-id><pub-id pub-id-type="pmid">33103907</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Stefanoni</surname><given-names>D</given-names></name><name><surname>Reisz</surname><given-names>JA</given-names></name><name><surname>Nemkov</surname><given-names>T</given-names></name><name><surname>Bertolone</surname><given-names>L</given-names></name><name><surname>Francis</surname><given-names>RO</given-names></name><name><surname>Hudson</surname><given-names>KE</given-names></name><name><surname>Zimring</surname><given-names>JC</given-names></name><name><surname>Hansen</surname><given-names>KC</given-names></name><name><surname>Hod</surname><given-names>EA</given-names></name><name><surname>Spitalnik</surname><given-names>SL</given-names></name><name><surname>D’Alessandro</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status</article-title><source>JCI Insight</source><volume>5</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1172/jci.insight.140327</pub-id><pub-id pub-id-type="pmid">32559180</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varatharajah</surname><given-names>N</given-names></name><name><surname>Rajah</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microthrombotic complications of COVID-19 are likely due to embolism of circulating endothelial derived ultralarge von willebrand factor (eulvwf) decorated-platelet strings</article-title><source>Federal Practitioner</source><volume>37</volume><fpage>e1</fpage><lpage>e2</lpage><pub-id pub-id-type="pmid">32489244</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Violi</surname><given-names>F</given-names></name><name><surname>Ceccarelli</surname><given-names>G</given-names></name><name><surname>Loffredo</surname><given-names>L</given-names></name><name><surname>Alessandri</surname><given-names>F</given-names></name><name><surname>Cipollone</surname><given-names>F</given-names></name><name><surname>D’ardes</surname><given-names>D</given-names></name><name><surname>D’Ettorre</surname><given-names>G</given-names></name><name><surname>Pignatelli</surname><given-names>P</given-names></name><name><surname>Venditti</surname><given-names>M</given-names></name><name><surname>Mastroianni</surname><given-names>CM</given-names></name><name><surname>Pugliese</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Albumin supplementation dampens hypercoagulability in covid-19: a preliminary report</article-title><source>Thrombosis and Haemostasis</source><volume>121</volume><fpage>102</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1055/s-0040-1721486</pub-id><pub-id pub-id-type="pmid">33368057</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>YM</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>ZG</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Tao</surname><given-names>ZW</given-names></name><name><surname>Tian</surname><given-names>JH</given-names></name><name><surname>Pei</surname><given-names>YY</given-names></name><name><surname>Yuan</surname><given-names>ML</given-names></name><name><surname>Zhang</surname><given-names>YL</given-names></name><name><surname>Dai</surname><given-names>FH</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>QM</given-names></name><name><surname>Zheng</surname><given-names>JJ</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Holmes</surname><given-names>EC</given-names></name><name><surname>Zhang</surname><given-names>YZ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A new coronavirus associated with human respiratory disease in China</article-title><source>Nature</source><volume>579</volume><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id><pub-id pub-id-type="pmid">32015508</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81316.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Baiocchi</surname><given-names>Robert</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rs6vg23</institution-id><institution>The Ohio State University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.03.31.22273226" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.31.22273226"/></front-stub><body><p>This report illustrates a comprehensive account detailing the marked alteration of red blood cell (RBC) morphology that occurs with COVID-19 infection. A particularly important result is the observation that RBC morphology is dramatically affected by plasma from COVID-19 patients and reversible with plasma from healthy donors. The claims of the manuscript are well supported by the data, and the approaches used are thoughtful and rigorous. The results are important for consideration of the broader pathophysiology of COVID-19, particularly with regard to the impact on vascular biology and will be of interest to the readership of <italic>eLife</italic>.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81316.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Baiocchi</surname><given-names>Robert</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rs6vg23</institution-id><institution>The Ohio State University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Graham</surname><given-names>Michael</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01y2jtd41</institution-id><institution>University of Wisconsin-Madison</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Misbah</surname><given-names>Chaouqi</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.03.31.22273226">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2022.03.31.22273226v2">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Michael Graham (Reviewer #1); Chaouqi Misbah (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>My question in the public review about the role of dilution in the observations is my primary reservation about the publication of this interesting manuscript in its current state.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>Overall, the study is relevant to the community working on the multifactorial effect of Covid-19. The paper is well written, and it deserves publication after the authors have addressed the following points</p><p>1) I was a bit surprised by the fact that both PinP and CinP RBCs do not show clusters. It seems to mean that either (i) plasma of patients is altered significantly so that fibrinogen (among other molecules) has been altered, in a way that depletion force is weak (if we admit depletion mode as the mechanism responsible for clustering) (ii) or RBCs membrane is altered, if one admits the bridging mode to be responsible for aggregation. These questions need further discussion, and experimental support, if possible.</p><p>2) Often clustering is associated with fibrinogen, but the role of albumin, as well as Igg antibodies, is often not stressed enough. It is reported here that in control plasma albumin is more abundant. Would that explain partially the point raised in 1) above? Did the authors examine Igg in control and compared it to patients' plasma? At least it would be nice to discuss these issues in the revised version.</p><p>3) As explained above in 1) clusters are absent in patient plasma. At the same time, it is known that blood occlusion is a major cause of patients' death. Of course, many other factors can enter into play for blood occlusion. Does this study inform us of the role of this finding in the formation of blood occlusion? Maybe the interaction among RBCs is so weak that a small stress may dissociate them. Can the authors comment on documented origins of vessel occlusions?</p><p>4) I have a naive question: is it known, or not, if cytokines have any effect on RBCs shapes, on plasma, or on collective effects, such as firm cluster formation?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81316.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>Overall, the study is relevant to the community working on the multifactorial effect of Covid-19. The paper is well written, and it deserves publication after the authors have addressed the following points</p><p>1) I was a bit surprised by the fact that both PinP and CinP RBCs do not show clusters. It seems to mean that either (i) plasma of patients is altered significantly so that fibrinogen (among other molecules) has been altered, in a way that depletion force is weak (if we admit depletion mode as the mechanism responsible for clustering) (ii) or RBCs membrane is altered, if one admits the bridging mode to be responsible for aggregation. These questions need further discussion, and experimental support, if possible.</p></disp-quote><p>We thank the reviewer for raising this important question. We measured the fibrinogen levels of the patients (see Figure 1-source data 1: a supplementary table containing the patient information), which exhibit on average higher values than for healthy controls (patients: mean: 427 mg/dL; min: 276 mg/dL; max: 624 mg/dL). Increased fibrinogen levels lead to increased clustering and sedimentation of RBCs (e.g., Darras et al., PRL 2022, https://doi.org/10.1103/PhysRevLett.128.088101; and Dasanna et al., PRE 2022, https://doi.org/10.1103/PhysRevE.105.024610). However, here we find that patients show a reduced number of RBC clusters in stasis (Figure 1B and Figure 1—figure supplement 2) as compared to healthy controls, although they exhibit on average increased fibrinogen levels. Therefore, we think that the strong alterations in the RBC shapes of patients (e.g., the presence of sphero-echinocytes) is the driving force that hinders the formation of RBC aggregates, irrespective of the aggregation mode (depletion/bridging).</p><p>We added a corresponding sentence in the Discussion section regarding the RBC shape and clustering in stasis.</p><disp-quote content-type="editor-comment"><p>2) Often clustering is associated with fibrinogen, but the role of albumin, as well as Igg antibodies, is often not stressed enough. It is reported here that in control plasma albumin is more abundant. Would that explain partially the point raised in 1) above? Did the authors examine Igg in control and compared it to patients' plasma? At least it would be nice to discuss these issues in the revised version.</p></disp-quote><p>We measured the albumin levels of the patients (see Figure 1-source data 1: a supplementary table containing the patient information), which exhibit smaller values than for healthy controls (patients: mean:2.9 mg/dL; min: 1.8 mg/dL; max: 3.3 mg/dL). We did not measure immunoglobulins levels. Although albumin (as well as immunoglobulins like IgG and IgM) can play a role in clustering, fibrinogen is a more efficient aggregation-promoting agent of RBCs. However, as stated in the response to comment 1, reviewer 2, we hypothesize that the main reason why RBCs in patient plasma do not form clusters is the presence of sheroechinocytes that prevent the cells from forming RBC aggregates.</p><disp-quote content-type="editor-comment"><p>3) As explained above in 1) clusters are absent in patient plasma. At the same time, it is known that blood occlusion is a major cause of patients' death. Of course, many other factors can enter into play for blood occlusion. Does this study inform us of the role of this finding in the formation of blood occlusion? Maybe the interaction among RBCs is so weak that a small stress may dissociate them. Can the authors comment on documented origins of vessel occlusions?</p></disp-quote><p>We thank the reviewer for this interesting comment. Under low shear rates and deformations, RBCs form rouleaux that can form larger clusters. However, under flow conditions, as is in the circulatory system, rouleaux structures would break up, and hence, such aggregates are not relevant for blood occlusions, as stated by the reviewer. Nevertheless, patient RBCs exhibit a strong impairment in cell deformability. Therefore, RBCs are not able to adapt their shape to the flow conditions, which leads to large y-deviations in our study (Figure 2D and Figure 1—figure supplement 1). Since a decreased deformability can result in complications such as damage to the endothelial cells lining the blood vessel walls (e.g., Caruso et al., 2022), we think that the severe shape and deformability impairment of patient RBCs contributes to the severity of COVID-19.</p><disp-quote content-type="editor-comment"><p>4) I have a naive question: is it known, or not, if cytokines have any effect on RBCs shapes, on plasma, or on collective effects, such as firm cluster formation?</p></disp-quote><p>We thank the reviewer for this comment and it is indeed not naïve. As cytokines affect various blood cells, we suspect there is a complex effect of cytokines on the RBC shape. However, these concrete effects are beyond the scope of the current manuscript.</p></body></sub-article></article>